Image

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

Exploring new treatments for B-cell Lymphoma patients.

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study aims to test the safety and dosage of two new drugs, KITE-363 and KITE-753, for people whose B-cell lymphoma (a type of blood cancer) has returned or not responded to other treatments. Participants will continue in a long-term follow-up study for up to 15 years. To join, you must have relapsed or refractory B-cell lymphoma, at least one measurable tumor, and healthy organ and bone marrow function. You can't join if you've had certain other cancers, recent stem cell transplants, infections that need IV drugs, or certain heart or immune system problems. Pregnant or breastfeeding women can't participate due to risks to the baby.

  • Length of Study: Up to 15 years in the long-term follow-up study.
  • Compensation: Details not provided, check with the study team.
  • Risks: Potential side effects from study drugs and preparative chemotherapy.

Discuss with your doctor to see if this study fits your health needs and conditions. Make sure to understand all requirements and risks before deciding to participate.

Print
Study details
    Relapsed and/or Refractory B-cell Lymphoma

NCT04989803

Kite, A Gilead Company

26 April 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.